HL: to what extent does bleomycin pulmonary toxicity affect outcomes?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In patients with Hodgkin's lymphoma (HL), neither bleomycin pulmonary toxicity (BPT) nor bleomycin discontinuation had a meaningful negative effect on survival outcomes.

Why this matters

  • Patients receiving bleomycin-containing chemotherapy are at significant risk for morbidity...